AstraZeneca Pharma India Limited
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ASTRAZEN.NS | APLLTD.NS | NATCOPHARM.NS | IPCALAB.NS | IOLCP.NS | ABBOTINDIA.NS | |
|---|---|---|---|---|---|---|
| Market cap | 157.35B | 175.63B | 156.27B | 494.62B | 55.50B | 565.34B |
| P/E (TTM) | 92.8 | 20.8 | 12.6 | 37.8 | 27.3 | 35.0 |
| Forward P/E | — | 18.2 | 16.8 | 27.7 | 17.5 | 29.4 |
| Price/book | 18.0 | 3.0 | 1.5 | 6.1 | 2.9 | 11.8 |
| Dividend yield | 0.57% | 1.32% | 0.75% | 0.30% | 0.54% | 1.94% |
| 1-year change | −30.65% | −0.94% | −1.47% | +51.13% | +102.86% | −7.93% |
| Today | −1.16% | −1.46% | +1.00% | −1.14% | +2.89% | −1.90% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All ASTRAZEN.NS news ›AstraZeneca Pharma India ESG Rating 73 FY2025-26
Kalkine India AstraZeneca Pharma India (NSE:ASTRAZEN): What Does Its ESG Rating of 73 Mean? Source: Krish Capital Pty Ltd AstraZeneca Pharma India Limited (NSE:ASTRAZEN) disclosed on 16 October 2026 that NSE Sustainability Ratings and…
More from 1 other outlet
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- kalkine.co.in1
- scanx.trade1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.